Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010264
Filing Date
2025-05-14
Accepted
2025-05-14 16:05:51
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 678132
2 EX-31.1 ex31-1.htm EX-31.1 11853
3 EX-31.2 ex31-2.htm EX-31.2 11714
4 EX-32.1 ex32-1.htm EX-32.1 6994
5 EX-32.2 ex32-2.htm EX-32.2 6924
  Complete submission text file 0001641172-25-010264.txt   3906401

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aimd-20250331.xsd EX-101.SCH 31966
7 XBRL CALCULATION FILE aimd-20250331_cal.xml EX-101.CAL 45465
8 XBRL DEFINITION FILE aimd-20250331_def.xml EX-101.DEF 172355
9 XBRL LABEL FILE aimd-20250331_lab.xml EX-101.LAB 271551
10 XBRL PRESENTATION FILE aimd-20250331_pre.xml EX-101.PRE 232678
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 397947
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41461 | Film No.: 25945349
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)